Janus Henderson Investors US’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$118M	Buy	3,418,861 +26,690	+0.8%	+$942K	0.1%	263
2016 Q4	$97.8M	Buy	3,392,171 +195,089	+6%	+$5.16M	0.08%	302
2016 Q3	$102M	Sell	3,197,082 -4,533	-0.1%	-$154K	0.09%	299
2016 Q2	$104M	Buy	3,201,615 +503,549	+19%	+$16.9M	0.09%	282
2016 Q1	$75.4M	Buy	2,698,066 +1,071,819	+66%	+$23.4M	0.07%	338
2015 Q4	$58M	Buy	1,626,247 +6,710	+0.4%	+$236K	0.05%	383
2015 Q3	$53.6M	Sell	1,619,537 -1,400,975	-46%	-$58.3M	0.05%	400
2015 Q2	$126M	Buy	3,020,512 +206,363	+7%	+$7.99M	0.1%	262
2015 Q1	$91.7M	Buy	2,814,149 +160,767	+6%	+$5.53M	0.08%	327
2014 Q4	$84.2M	Buy	2,653,382 +40,039	+2%	+$1.14M	0.07%	341
2014 Q3	$64.7M	Buy	2,613,343 +1,300,618	+99%	+$30.4M	0.06%	365
2014 Q2	$29.7M	Buy	1,312,725 +82,916	+7%	+$1.73M	0.03%	505
2014 Q1	$29.9M	Buy	1,229,809 +296,816	+32%	+$7.51M	0.03%	496
2013 Q4	$23.3M	Buy	+932,993	New	+$22M	0.02%	515